Get started
Live feed
SECFilingvia Quantisnow
Coeptis Therapeutics Holdings Inc. logo

COEP: SEC Form S-1 filed by Coeptis Therapeutics Holdings Inc.

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for COEP

Across the 3 sessions after earlier COEP headlines, the stock closed higher 2 times and lower 1 times, with a median move of 6.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

COEP close-to-close change in the session after earlier headlines
SessionEarlier headlineCOEPSPY
Apr 7, 2026Coeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing Application-10.5%+0.0%
Feb 6, 2026Coeptis Receives Shareholder Approval Towards Z Squared Merger+6.2%+1.9%
Jan 6, 2026Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared+2.6%+0.6%
Quantisnow market dataNASDAQ
Coeptis Therapeutics Holdings Inc. logo
COEP
Coeptis Therapeutics Holdings Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Listed since
2020
Get push alerts for COEP

Follow COEP and get a push notification the moment its next story breaks.

Full COEP profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COEP (Coeptis Therapeutics Holdings Inc.) and more on Quantisnow.